Mesenchymal stromal cell therapy for pancreatitis: Progress and challenges

Area of Science:

• Gastroenterology
• Regenerative Medicine
• Cell Therapy

Background:

• Pancreatitis, a common gastrointestinal disease, lacks effective treatments, especially for severe acute and chronic forms.
• Mesenchymal stromal cells (MSCs) possess regenerative, anti-inflammatory, and immunomodulatory properties beneficial for tissue repair.

Purpose of the Study:

• To review the potential and challenges of using MSCs for treating acute and chronic pancreatitis.
• To discuss the underlying molecular mechanisms of MSC-based pancreatitis therapy.

Main Methods:

• Literature review of preclinical studies on MSCs in animal models of pancreatitis.
• Analysis of reported therapeutic effects and proposed mechanisms of MSCs.

Main Results:

• MSCs have demonstrated significant therapeutic efficacy in animal models of acute and chronic pancreatitis.
• The precise molecular mechanisms driving MSC efficacy in pancreatitis remain incompletely understood.

Conclusions:

• MSCs represent a promising cell-based therapy for pancreatitis, supported by preclinical evidence.
• Clarifying molecular mechanisms and overcoming challenges are crucial for advancing MSCs to clinical pancreatitis treatment.